Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

Estrogen receptor beta is involved in skeletal muscle hypertrophy induced by the phytoecdysteroid ecdysterone

Maria Kristina ParrCenter for Preventive Doping Research German Sport University Cologne GermanyPiwen ZhaoSchool of Preclinical Medicine Beijing University of Chinese Medicine Bejing P. R. ChinaOliver HauptCenter for Preventive Doping Research German Sport University Cologne GermanySandrine Tchoukouegno NgueuCenter for Preventive Doping Research German Sport University Cologne GermanyJonas HengevoßCenter for Preventive Doping Research German Sport University Cologne GermanyKarl Heinrich FritzemeierBayer Pharma AG Berlin GermanyM. PiechottaClinic for Cattle, Endocrinology Laboratory University of Veterinary Medicine Hannover Hannover GermanyNils E. SchlörerInstitute of Organic Chemistry University of Cologne GermanyPeter MuhnBayer Pharma AG Berlin GermanyWenya ZhengCenter for Preventive Doping Research German Sport University Cologne GermanyMingyong XieState Key Laboratory of Food Science and Technology Nanchang University Nanchang P. R. ChinaPatrick DielCenter for Preventive Doping Research German Sport University Cologne Germany
2014en
ABI

Аннотация

SCOPE: The phytoectysteroid ecdysterone (Ecdy) was reported to stimulate protein synthesis and enhance physical performance. The aim of this study was to investigate underlying molecular mechanisms particularly the role of ER beta (ERβ). RESULTS: In male rats, Ecdy treatment increased muscle fiber size, serum IGF-1 increased, and corticosteron and 17β-estradiol (E2) decreased. In differentiated C2C12 myoblastoma cells, treatment with Ecdy, dihydrotestosterone, IGF-1 but also E2 results in hypertrophy. Hypertrophy induced by E2 and Ecdy could be antagonized with an antiestrogen but not by an antiandrogen. In HEK293 cells transfected with ER alpha (ERα) or ERβ, Ecdy treatment transactivated a reporter gene. To elucidate the role of ERβ in Ecdy-mediated muscle hypertrophy, C2C12 myotubes were treated with ERα (ALPHA) and ERβ (BETA) selective ligands. Ecdy and BETA treatment but not ALPHA induced hypertrophy. The effect of Ecdy, E2, and BETA could be antagonized by an ERβ-selective antagonist (ANTIBETA). In summary, our results indicate that ERβ is involved in the mediation of the anabolic activity of the Ecdy. CONCLUSION: These findings provide new therapeutic perspectives for the treatment of muscle injuries, sarcopenia, and cachectic disease, but also imply that such a substance could be abused for doping purposes.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0